Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (N-Term) Peptide
LRRFIP1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN979608
Aperçu rapide pour Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (N-Term) Peptide (ABIN979608)
Antigène
LRRFIP1
(Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LRRFIP1 antibody (Catalog #: ARP38506_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Sujet
-
LRRFIP1 is a transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. LRRFIP1 may control smooth muscle cells proliferation following artery injury throu
Alias Symbols: FLAP-1, FLIIAP1, GCF-2, GCF2, HUFI-1, MGC10947, MGC119738, MGC119739, TRIP, FLAP1
Protein Interaction Partner: FLII,FLII
Protein Size: 784 -
Poids moléculaire
- 86 kDa
-
ID gène
- 9208
-
NCBI Accession
- NM_004735, NP_004726
Antigène
-
Vous êtes ici:
